Edarbi and Edarbyclor for hypertensionTakeda Canada is introducing a new angiotensin II blocker (ARB) for the treatment of hypertension. Press Review - April 5, 2013Check out our review of recent medical stories in the media - Top Story: Personalized prescriptions reduce side effects, increase efficiency. Read this and Tell your patients that doing their taxes leads to better health Your patients need to know that taking advantage of tax credits can go a long way to making things easier for low-income Canadians, both in health and finances Bystolic: new beta-blocker for hypertension Forest Laboratories will soon launch a new once-daily beta-blocker for the treatment of mild to moderate essential hypertension. Adverse Reactions: ACEI-induced angiodema ACEI-induced angioedema Clinical Notes: Updated Canadian guidelines for managing dyslipidemia Stroke? Rush some blood to the head Non-invasive angina treatment shows promise in cerebral ischemia CLINICAL PEARLS: Don’t stop steroids in kids with asthma Eat Mediterranean Optimal management of post-stroke depression and vascular cognitive impairment Stroke care recommendations updated to promote optimal detection and management of post-stroke depression and vascular cognitive impairment. First Previous 55 56 57 58 59 Next Last
